Business · 02/03/2023Updated: 10/17/2026 · 1 min read
Joint Meeting of the Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Cancellation
Summary
The meeting of the Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee, originally scheduled for March 20, 2023, has been cancelled due to its no longer being needed, as announced in the Federal Register on January 30, 2023.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →